Matches in Wikidata for { <http://www.wikidata.org/entity/Q38126859> ?p ?o ?g. }
- Q38126859 description "article científic" @default.
- Q38126859 description "article scientifique" @default.
- Q38126859 description "articol științific" @default.
- Q38126859 description "articolo scientifico" @default.
- Q38126859 description "artigo científico" @default.
- Q38126859 description "artigo científico" @default.
- Q38126859 description "artigo científico" @default.
- Q38126859 description "artikel ilmiah" @default.
- Q38126859 description "artikull shkencor" @default.
- Q38126859 description "artículo científico" @default.
- Q38126859 description "artículu científicu espublizáu en 2013" @default.
- Q38126859 description "bilimsel makale" @default.
- Q38126859 description "scienca artikolo" @default.
- Q38126859 description "scientific article published on 05 August 2013" @default.
- Q38126859 description "scientific article published on 05 August 2013" @default.
- Q38126859 description "scientific article published on 05 August 2013" @default.
- Q38126859 description "vedecký článok" @default.
- Q38126859 description "vetenskaplig artikel" @default.
- Q38126859 description "videnskabelig artikel" @default.
- Q38126859 description "vitenskapelig artikkel" @default.
- Q38126859 description "vitskapeleg artikkel" @default.
- Q38126859 description "vědecký článek" @default.
- Q38126859 description "wetenschappelijk artikel" @default.
- Q38126859 description "wissenschaftlicher Artikel" @default.
- Q38126859 description "наукова стаття, опублікована в серпні 2013" @default.
- Q38126859 description "научная статья" @default.
- Q38126859 description "научни чланак" @default.
- Q38126859 description "מאמר מדעי" @default.
- Q38126859 description "مقالة علمية نشرت في 05 أغسطس 2013" @default.
- Q38126859 description "বৈজ্ঞানিক নিবন্ধ" @default.
- Q38126859 name "Pertuzumab: a new targeted therapy for HER2-positive metastatic breast cancer" @default.
- Q38126859 name "Pertuzumab: a new targeted therapy for HER2-positive metastatic breast cancer" @default.
- Q38126859 name "Pertuzumab: a new targeted therapy for HER2-positive metastatic breast cancer" @default.
- Q38126859 type Item @default.
- Q38126859 label "Pertuzumab: a new targeted therapy for HER2-positive metastatic breast cancer" @default.
- Q38126859 label "Pertuzumab: a new targeted therapy for HER2-positive metastatic breast cancer" @default.
- Q38126859 label "Pertuzumab: a new targeted therapy for HER2-positive metastatic breast cancer" @default.
- Q38126859 prefLabel "Pertuzumab: a new targeted therapy for HER2-positive metastatic breast cancer" @default.
- Q38126859 prefLabel "Pertuzumab: a new targeted therapy for HER2-positive metastatic breast cancer" @default.
- Q38126859 prefLabel "Pertuzumab: a new targeted therapy for HER2-positive metastatic breast cancer" @default.
- Q38126859 P1433 Q38126859-EB2BED5F-7B27-43C6-BD26-DE13E44E0B4F @default.
- Q38126859 P1476 Q38126859-69F35A2F-C63D-4190-8E60-D8434B8CD589 @default.
- Q38126859 P2093 Q38126859-391EA647-776C-4921-8EF6-621BA47E76A5 @default.
- Q38126859 P2093 Q38126859-7F6A20BB-0466-4610-A1C2-5D263A1B47D3 @default.
- Q38126859 P2093 Q38126859-CDE00759-AC20-48E6-A210-178F4C687325 @default.
- Q38126859 P2860 Q38126859-0ED6EAA9-648F-4AF1-A59F-07C4D71276D6 @default.
- Q38126859 P2860 Q38126859-0F3C5BF3-DBA1-4B0A-B1DF-D1AC055DD45B @default.
- Q38126859 P2860 Q38126859-146A5EEC-788F-49AC-92DC-45ED75C7FD56 @default.
- Q38126859 P2860 Q38126859-2E6DE38D-1717-4C5F-B8D4-6C11AE79BD05 @default.
- Q38126859 P2860 Q38126859-32B716CB-EEF7-467B-B601-35B66C210F01 @default.
- Q38126859 P2860 Q38126859-399F4DE9-E88B-4C6F-B9CE-1C3E2928F195 @default.
- Q38126859 P2860 Q38126859-3A2FE499-D2A9-4E04-BE75-235F83542200 @default.
- Q38126859 P2860 Q38126859-3FC13A16-656D-4405-862C-7251B1022ABE @default.
- Q38126859 P2860 Q38126859-4A303E60-C381-4405-B3DF-E313C6A8B8AC @default.
- Q38126859 P2860 Q38126859-4CCB980C-DAF1-407B-9CBF-4F01960FCE56 @default.
- Q38126859 P2860 Q38126859-4F630E76-3B97-4B3C-A204-83CDA7486324 @default.
- Q38126859 P2860 Q38126859-5C4031A2-9887-4711-9A98-517DF77F82CE @default.
- Q38126859 P2860 Q38126859-619AD08B-060D-465C-A1FD-65F3FFCCDFE0 @default.
- Q38126859 P2860 Q38126859-639C3AFB-B492-4BC6-B73A-88E48D8CB3DE @default.
- Q38126859 P2860 Q38126859-6A787A6D-A3E4-4E3C-935F-CA8D0CF3AFAB @default.
- Q38126859 P2860 Q38126859-7B6B5CF4-876F-47BE-B1C0-4203CA37C1C6 @default.
- Q38126859 P2860 Q38126859-9A28C37F-2D62-41AF-8C3C-A92B5DE2531C @default.
- Q38126859 P2860 Q38126859-9E19159C-6211-49B9-977F-B81EC3074248 @default.
- Q38126859 P2860 Q38126859-A1FFA47B-C3FE-4407-9196-851741D4C7CF @default.
- Q38126859 P2860 Q38126859-A4842740-25B2-44B0-83A6-DA83D6DEAB64 @default.
- Q38126859 P2860 Q38126859-AA45099D-1BD9-493A-80E8-D3DD2B138F98 @default.
- Q38126859 P2860 Q38126859-BDA4FE6F-B09C-4DBE-A2D1-FC60BF34B0AC @default.
- Q38126859 P2860 Q38126859-C08A2052-A9B2-41E1-AE81-437090480815 @default.
- Q38126859 P2860 Q38126859-C80A3C32-4AE7-4760-87D8-BEF27EA2D317 @default.
- Q38126859 P2860 Q38126859-CDB688B5-34A3-4E50-8B5A-0C494810D17C @default.
- Q38126859 P2860 Q38126859-CF8EBE12-9B98-423D-8CDF-3EDB934421CC @default.
- Q38126859 P2860 Q38126859-D844337E-3159-4A75-8DB7-0853D3228A87 @default.
- Q38126859 P2860 Q38126859-DC130306-30F5-4F85-A439-BF35A3A1C4A8 @default.
- Q38126859 P2860 Q38126859-E16AD25D-33E1-45E6-894A-1B8EDF187A51 @default.
- Q38126859 P2860 Q38126859-E6028063-58E9-46E8-8670-BA5A9A3EB177 @default.
- Q38126859 P2860 Q38126859-EC6A2A30-3A43-413E-901F-CCAFDEED8099 @default.
- Q38126859 P2860 Q38126859-EDDB8527-CD29-488D-B990-5F3817894703 @default.
- Q38126859 P2860 Q38126859-F4A09E95-EA38-4E2E-BC05-084FC6A7AF52 @default.
- Q38126859 P2860 Q38126859-F855B501-7720-4686-A2D1-D5C0BBD8B71E @default.
- Q38126859 P2860 Q38126859-FD93FE18-24A7-4E0A-9854-97D36C09DE32 @default.
- Q38126859 P304 Q38126859-A75D1AF2-7304-42D4-B99B-0E9DF2AE7672 @default.
- Q38126859 P31 Q38126859-2B67A0E9-4B5B-4F0A-9664-89E7DD5A6C1D @default.
- Q38126859 P356 Q38126859-166B99DE-E854-4B3C-9C90-2D1FB6BDD5DC @default.
- Q38126859 P407 Q38126859-DA0729B8-4D79-4BB7-AFB2-DB4FAA8D6EEA @default.
- Q38126859 P433 Q38126859-2B28F495-95D1-4AF1-8331-3380C1889125 @default.
- Q38126859 P478 Q38126859-72DF679A-EBCA-475D-AEB5-30AA8F94C397 @default.
- Q38126859 P577 Q38126859-28BA97BD-0B8C-4A73-90D8-A6F1992956F7 @default.
- Q38126859 P698 Q38126859-6E88AA10-83B6-4BC9-B306-0569C9A65581 @default.
- Q38126859 P921 Q38126859-B6721A6A-C4C2-4BA9-9270-A6C70E5BC541 @default.
- Q38126859 P356 PHAR.1338 @default.
- Q38126859 P698 23918291 @default.
- Q38126859 P1433 Q7180800 @default.
- Q38126859 P1476 "Pertuzumab: a new targeted therapy for HER2-positive metastatic breast cancer" @default.
- Q38126859 P2093 "Chad M Barnett" @default.
- Q38126859 P2093 "Karen R Eckmann" @default.
- Q38126859 P2093 "Stephanie J Malenfant" @default.
- Q38126859 P2860 Q24648517 @default.
- Q38126859 P2860 Q24806486 @default.
- Q38126859 P2860 Q24806542 @default.
- Q38126859 P2860 Q27640593 @default.